A detailed history of Signaturefd, LLC transactions in Ptc Therapeutics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 363 shares of PTCT stock, worth $14,240. This represents 0.0% of its overall portfolio holdings.

Number of Shares
363
Previous 385 5.71%
Holding current value
$14,240
Previous $11,000 18.18%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 21, 2024

SELL
$30.39 - $37.66 $668 - $828
-22 Reduced 5.71%
363 $13,000
Q2 2024

Jul 29, 2024

BUY
$24.69 - $40.12 $1,629 - $2,647
66 Added 20.69%
385 $11,000
Q1 2024

May 03, 2024

SELL
$24.15 - $31.95 $3,236 - $4,281
-134 Reduced 29.58%
319 $9,000
Q4 2023

Jan 31, 2024

BUY
$18.07 - $29.37 $6,938 - $11,278
384 Added 556.52%
453 $12,000
Q3 2023

Nov 03, 2023

BUY
$22.41 - $41.99 $537 - $1,007
24 Added 53.33%
69 $1,000
Q2 2023

Aug 01, 2023

SELL
$40.4 - $59.1 $1,010 - $1,477
-25 Reduced 35.71%
45 $1,000
Q1 2023

Apr 28, 2023

BUY
$38.16 - $48.86 $953 - $1,221
25 Added 55.56%
70 $3,000
Q4 2022

Jan 27, 2023

SELL
$33.53 - $54.79 $1,408 - $2,301
-42 Reduced 48.28%
45 $1,000
Q3 2022

Nov 08, 2022

BUY
$41.85 - $53.85 $1,757 - $2,261
42 Added 93.33%
87 $4,000
Q2 2022

Aug 10, 2022

SELL
$25.6 - $45.23 $2,432 - $4,296
-95 Reduced 67.86%
45 $2,000
Q1 2022

May 02, 2022

BUY
$33.33 - $44.6 $1,933 - $2,586
58 Added 70.73%
140 $5,000
Q4 2021

Jan 25, 2022

BUY
$35.36 - $41.86 $2,086 - $2,469
59 Added 256.52%
82 $3,000
Q3 2021

Oct 28, 2021

BUY
$37.01 - $44.74 $851 - $1,029
23 New
23 $1,000
Q2 2021

Jul 26, 2021

SELL
$37.95 - $49.37 $7,855 - $10,219
-207 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$46.8 - $68.92 $608 - $895
13 Added 6.7%
207 $10,000
Q4 2020

Feb 11, 2021

BUY
$47.96 - $67.64 $431 - $608
9 Added 4.86%
194 $12,000
Q3 2020

Nov 03, 2020

BUY
$45.41 - $57.07 $8,400 - $10,557
185 New
185 $9,000

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $2.81B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Signaturefd, LLC Portfolio

Follow Signaturefd, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.